Ke. Mccarson et al., CHRONIC NONPEPTIDE NEUROKININ RECEPTOR ANTAGONIST TREATMENT ALTERS STRIATAL TACHYKININ PEPTIDE AND RECEPTOR GENE-EXPRESSION IN THE RAT, Neuroscience letters, 251(2), 1998, pp. 113-116
The neurokinin-l receptor (NK-1R) and the tachykinin peptide substance
P (SP) are found throughout the central nervous system (CNS) and are
involved in the regulation of sensory, cardiovascular, and inflammator
y function. Selective antagonists for the NK-1R such as CP-122,721 blo
ck NK-1R-mediated responses both in vitro and in vivo. This study inve
stigated the effects of long-term daily CP-122,721 treatment on gene e
xpression of SP and the NK-1R in the striatum and hindbrain of the rat
. The striatum and hindbrain of rats receiving CP122,721 (5, 30, or 15
0 mg/kg) once-daily for 30 days were assayed for SP- and NK-1R-encodin
g mRNAs using solution hybridization-nuclease protection assays. Resul
ts show that treatment with CP-122,721 significantly increased SP-enco
ding mRNA and NK-1R mRNA levels in the striatum, but not in the hindbr
ain. The ability of CP122,721 to alter SP and NK-1R gene expression ma
y provide a use for non-peptide neurokinin receptor antagonists in the
modulation of systems regulated by NK-1R function. (C) 1998 Elsevier
Science Ireland Ltd. All rights reserved.